Company lists
The Missouri edition · 2026

Life sciencescompanies in Missouri

Genomics, oncology, life sciences technology, infectious diseases, listed companies and more: the companies building life sciences in Missouri, with their founders, funding, team size and business models.

144 company profiles34 with recorded fundingNovember 2026 edition
Missouri · Photo: Wikimedia Commons (CC BY 3.0)

Recent life sciences business events in the United States

Funding, M&A, contract wins and launches involving 27,407 life sciences companies in the United States, last 24 months: 1640 M&A deals · 1543 funding rounds · 557 Contracts · 73 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jul 2026.

LaunchRobotic Connective Network

Nightfood

Nightfood Holdings Inc. (OTCQB: NGTF), operating under the TechForce Robotics brand, is engineering a solution to this problem with a proprietary Robotic Connective Network and…

Robotics
ContractInfrastructure

Sharp · client: Kddi

Electronics company Sharp is working with telco KDDI to build what it claims will be Asia's largest AI data center on the site of a former LCD screen manufacturing plant in Osaka, Japan.

AI data center
M&AAcquisition · Completed

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquires Mineralys therapeutics

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) during the fourth quarter, according to its…

Clinical-stage biopharmaceutical
M&AMerger · Announced

Ignite acquires Ignite Proteomics

The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.

Functional proteomics
ContractTechnology

Chai Discovery · client: Pfizer

Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…

Biopharmaceutical
FundingSenior Notes

IQVIA

IQVIA Holdings Inc. ('IQVIA') (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the 'Issuer'), priced an offering of €950,000,000 in aggregate principal amount of…

ContractSupply

Beijing mabworks biotech · client: Everest medicines

Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…

Pharmaceutical
FundingSeries B

Advanced nanotherapies

Advanced NanoTherapies (ANT) has successfully closed a significant Series B funding round, garnering over $31 million.

Investors S3 Ventures, T45 Fund
Medical device
FundingRegistered Direct Offering

Lixte Biotechnology Holdings

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in…

Pharmaceutical
ContractService

Hollister-Stier Laboratories LLC · client: Biomarin pharmaceutical

Hollister-Stier has agreed to filter and package an enzyme-replacement product for BioMarin Pharmaceutical Inc., of Novato, Calif.

Pharmaceutical
M&AAcquisition · Announced

Resmed acquires Noctrix health

announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million.

Medical technology
M&AMerger · Completed

B&C Telephone Inc. acquires Intouch solutions

B&C Telephone Inc., a Spokane-based company that sells and services commercial telephone systems, has merged with inTouch Solutions, a Boise-based telecommunication company.

Telecommunications
M&AAcquisition · Announced

The clorox company acquires Nutranext

Clorox will pay $700 million to acquire Nutranext, with the purchase price representing about 3.5 times calendar year 2017 sales.

Dietary and Nutritional Supplements
ContractService

Stellantis · client: Evera

With this agreement, Evera aims to rent 2,000 electric vehicles reconditioned by the Stellantis group by the end of 2027.

M&AAcquisition · Announced

Butterfly acquires Orgain

Butterfly, a LA-based private equity firm specializing in the food sector, has signed a definitive agreement to acquire a majority stake in Orgain, Inc., according to a press release.

Organic and clean nutrition products
FundingUnderwritten Offering

Mineralys therapeutics

The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be…

Investors BofA Securities, Goldman sachs, Evercore ISI
Biopharmaceutical
M&AAcquisition · Pending

Medtronic acquires Spr therapeutics

is currently finalizing the purchase of SPR Therapeutics

Medical device manufacturer
FundingPublic Offering

Avalo therapeutics

In first place was Avalo Therapeutics, which priced a $375 million public offering to advance the clinical development of its candidate abdakibart, including through its phase 3 topline…

Investors Na
Biotech
FundingPublic Offering

Editas medicine

In second place, gene editing company Editas Medicine announced a public offering of up to $319.4 million.

Investors Na
Biotech
M&AAcquisition · Announced

Tend health acquires The doctors

Green Cross Health surged by more than a third after it agreed to sell its medical arm, The Doctors, to iwi-backed digital-first health firm Tend Health for $270 million.

Healthcare
FundingSeries A

Endra

Stockholm-based AI startup Endra has raised $50 million in Series A funding to scale its platform that automates design work for mechanical, electrical, and plumbing (MEP) consultants.…

Investors Andreessen Horowitz, Notion capital, Norrsken vc
AI
LaunchVOXLS 20 C 225

Nikon Corporation

Nikon Corporation has launched the VOXLS 20 C 225, the latest addition to its VOXLS X-ray CT product lineup.

X-ray CT
FundingPublic Offering

Nrx pharmaceuticals

NRx Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock in an underwritten public offering with BTIG, LLC acting as the lead bookrunner and Lucid…

Investors BTIG, Lucid Capital
Biopharmaceutical
FundingNon-dilutive Capital

Apogee therapeutics

Apogee Therapeutics secured up to $1.3 billion in flexible, non-dilutive capital last month from Blackstone Life Sciences, including up to $800 million in synthetic royalty and access to…

Investors Blackstone Life Sciences
Biotech
FundingPublic Offering

Artiva biotherapeutics

It's also worth noting that Artiva Biotherapeutics wasn't far behind in fourth place after pricing a $300 million underwritten offering.

Investors Na
Biotech
M&AMerger · Announced

Avenzo therapeutics acquires Rallybio

NEW YORK – Rallybio will merge with Avenzo Therapeutics to develop several precision oncology assets, including CDK2 and CDK4 inhibitors and bispecific antibody-drug conjugates (ADCs).

Oncology
M&AAcquisition · Announced

Dragos acquires Phosphorus

Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.

Cybersecurity / device discovery and remediation software
M&AAcquisition · Announced

Rallybio acquires Avenzo therapeutics

Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…

Biotech

Life sciences companies in Missouri, by funding and team

Few life sciences companies in Missouri publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 144 active companies.

Showing 25 of 50

Developer of CAR-T cell therapy for treatingT-cell malignancies

Immunotherapy
US$250.73mSeries C · Aug 2025
51-22% vs previous recordLinkedIn · Jul 2026
Fee-for-service
8 yr2018
0none in 3 months · last posted Jun 2026

Developer of non-invasive biomarker tests for colorectal cancer

Genomics
US$218.95mSeries C · Jan 2025
73-16% vs previous recordLinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months · last posted Jun 2026

Innovating fluorescent technology for improved patient care and disease management

Nephrology
US$110.71mSeries D · Aug 2023
31+14% vs previous recordLinkedIn · Oct 2026
Subscription
15 yr2011
0none in 3 months

Developing neurostimulation treatment for drug-refractory gastroesophageal reflux disease (GERD)

Gastroenterology
US$75.78mSeries D · Dec 2018
4LinkedIn · Jul 2026
Physical commerce
17 yr2009
0none in 3 months

Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care

Surgical instruments
US$36.00mSeries C · Nov 2001
194-6% 12 mo to Dec 2023LinkedIn · Oct 2026
Commission on transaction / E-commerce - product
36 yr1990
0none in 3 months · last posted Mar 2026

Developer of robotic glove controlled by brain

Healthcare it
US$28.32mSeries A · Feb 2025
9+0% 12 mo to Dec 2022recorded Dec 2022
Physical commerce / Subscription
19 yr2007
0none in 3 months

Developer of therapeutics for the treatment of interventional immuno-oncology

Immunotherapy
US$28.11mSeries B · Feb 2023
20+55% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
18 yr2008
0none in 3 months

Developer of therapies for infectious disease prevention

Infectious diseases
US$28.00mSeries A · Sep 2025
1LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months

Developer of cardiac catheter for the treatment of cardiac diseases

Cardiac and vascular disorders
US$26.55mSeries B · Aug 2024
12+40% vs previous recordLinkedIn · Jul 2026
Physical commerce
11 yr2015
0none in 3 months

Developing small molecules targeting RGD-binding integrins to treat fibrotic diseases

Immunology
US$26.00mSeries A · Aug 2017
8-27% vs previous recordrecorded
E-commerce - product / Physical commerce
10 yr2016
0none in 3 months

Developer of advanced ultrasound imaging technology for medical diagnostics and interventions

Diversified medical devices
US$25.00mSeries A · Oct 2021
73LinkedIn · Jul 2026
Subscription
7 yr2019
0none in 3 months

Developer of next-generation trait delivery technology for higher-yielding crops and sustainable agriculture

Genomics
US$18.49mSeries B · Oct 2025
24+28% vs previous recordLinkedIn · Jul 2026
Physical commerce
10 yr2016
0none in 3 months

Scientific research products for university labs worldwide, advancing scientific discovery

Immunotherapy
US$17.00mSeries A · Feb 2017
—Not available
Fee-for-service
10 yr2016
0none in 3 months

Developer of therapeutic drugs for the treatment of cancer cachexia

Oncology
US$11.70mSeries B · Jan 2023
26-17% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months · last posted Jun 2026

Ophthalmic surgery solutions

Ophthalmology
US$10.88mSeries B · Oct 2013
5LinkedIn · Jul 2026
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months

Developer of wearable device for controlling appetite

Obesity
US$10.56mSeries A · Dec 2022
1LinkedIn · Jul 2026
E-commerce - product / Physical commerce
22 yr2004
0none in 3 months

Bacterial screening device for diagnosis and treatment of infectious diseases

Infectious diseases
US$7.70mSeries A · Aug 2015
16+17% vs previous recordLinkedIn · Jul 2026
Physical commerce
22 yr2004
0none in 3 months

Developer of biomaterials using dandelion as a sustainable resource

Genomics
US$6.32mSeries A · Apr 2020
6LinkedIn · Jul 2026
E-commerce - product / Physical commerce
18 yr2008
0none in 3 months

Provider of a real-world health data platform for research and development

Life sciences tech
US$6.00mSeed · Aug 2022
2+25% vs previous recordLinkedIn · Jul 2026
Subscription
6 yr2020
—No postings tracked

Developer of biotherapeutics for the treatment of multiple diseases

Genomics
US$5.00mSeries A · Apr 2019
3recorded
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months

Clinical trial management platform with patient-level AI solutions

Life sciences tech
US$4.77mSeed · Aug 2025
—Not available
Subscription
3 yr2023
—No postings tracked

Developer of superior efficacy cancer therapeutics

Oncology
US$3.94mSeries A · Jan 2021
4LinkedIn · Jul 2026
E-commerce - product / Physical commerce
15 yr2011
0none in 3 months

Developer of UV-light based device for surface and air disinfection

Hospital equipment
US$1.60mSeed · Dec 2024
13LinkedIn · Jul 2026
E-commerce - product / Physical commerce
10 yr2016
0none in 3 months

Transforming human apyrase into life-saving medicine for thrombotic diseases

Cardiac and vascular disorders
US$1.60mSeed · Jun 2002
1+0% 12 mo to Dec 2019LinkedIn · Jul 2026
Subscription
25 yr2001
0none in 3 months

Developer of a nanotechnology-based red blood cell substitute

Hematology
US$1.10mSeed · Jul 2022
23-60% vs previous recordLinkedIn · Jul 2026
Physical commerce
10 yr2016
0none in 3 months
50 of 144 companies shown here · the full list is on Radar
Fliar Radar

Explore all 144 life sciences companies in Missouri on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in Missouri on Radar
  • Every company, not just 50All 144 life sciences companies in Missouri, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in Missouri by what you are looking for

Browse top life sciences companies in Missouri across genomics, cancer research and medical technology. Find life sciences startups in Missouri and listed companies.

7 ways to explore life sciences in Missouri

Genomics and clinical genomics companiesOncology and cancer research companiesLife sciences technology and research platformsInfectious disease and diagnostics companiesPublic life sciences companies in MissouriLife sciences startups in Missouri

Genomics and clinical genomics companies

Explore Missouri companies developing genomic testing, analysis and research tools.

  1. Geneoscopy

    Developer of non-invasive biomarker tests for colorectal cancer

    Genomics
    See in list
  2. Plastomics

    Developer of next-generation trait delivery technology for higher-yielding crops and sustainable agriculture

    Genomics
    See in list
  3. Kultevat

    Developer of biomaterials using dandelion as a sustainable resource

    Genomics
    See in list
  4. Keystone Bio

    Developer of biotherapeutics for the treatment of multiple diseases

    Genomics
    See in list
  5. Pairidex

    Developer of personalized measurable residual disease detection for fusion-driven blood cancers

    Genomics
    See in list

Oncology and cancer research companies

Find life sciences companies focused on cancer therapies, testing and research.

  1. Wugen

    Developer of CAR-T cell therapy for treatingT-cell malignancies

    Immunotherapy
    See in list
  2. Geneoscopy

    Developer of non-invasive biomarker tests for colorectal cancer

    Genomics
    See in list
  3. Immunophotonics

    Developer of therapeutics for the treatment of interventional immuno-oncology

    Immunotherapy
    See in list
  4. Affigen

    Scientific research products for university labs worldwide, advancing scientific discovery

    Immunotherapy
    See in list
  5. Endevica Bio

    Developer of therapeutic drugs for the treatment of cancer cachexia

    Oncology
    See in list

Life sciences technology and research platforms

Browse technology platforms, tools and software supporting life sciences research.

  1. Curimeta

    Provider of a real-world health data platform for research and development

    Life sciences tech
    See in list
  2. Trially

    Clinical trial management platform with patient-level AI solutions

    Life sciences tech
    See in list
  3. Arch Innotek

    Engineering microorganisms to produce ingredients for human and animal health

    Life sciences platforms and tools
    See in list
  4. XNAT

    Open source imaging informatics software

    Life sciences tech
    See in list
  5. Synexis

    Tool for reduction of microbial levels in occupied spaces

    Life sciences platforms and tools
    See in list

Infectious disease and diagnostics companies

Discover companies developing infectious disease therapies, diagnostics and tests.

  1. LPOXY Therapeutics

    Developer of therapies for infectious disease prevention

    Infectious diseases
    See in list
  2. BacterioScan

    Bacterial screening device for diagnosis and treatment of infectious diseases

    Infectious diseases
    See in list
  3. Omniose

    Developer of polysaccharide conjugate vaccines against bacterial threats

    Immunotherapy
    Website
  4. Fimbrion Therapeutics

    Pioneering anti-virulence therapeutics for urinary tract infections and tuberculosis

    Infectious diseases
    Website
  5. MagBiosense

    POC device for cardiac disease diagnosis

    Cardiac and vascular disorders
    Website

Public life sciences companies in Missouri

Explore publicly listed life sciences companies in Missouri.

  1. Stereotaxis

    Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care

    Surgical instruments
    See in list
  2. Allied Healthcare Products

    Portfolio of respiratory medical devices

    Pulmonology
    See in list
  3. Reliv International

    Manufacturing and marketing a range of nutritional supplements

    Nutraceuticals tech
    See in list
3 companies in Missouri

Life sciences startups in Missouri

Find newer life sciences companies building products and services in Missouri.

  1. Trially

    Clinical trial management platform with patient-level AI solutions

    Life sciences tech
    See in list
  2. Pairidex

    Developer of personalized measurable residual disease detection for fusion-driven blood cancers

    Genomics
    See in list
  3. Buck Surgical

    Developer of medical devices for anastomotic procedures

    Surgical instruments
    See in list
  4. Definitive Diagnostics

    Provider of liquid biopsy platform for early detection of cancer

    Oncology
    See in list
  5. SunFlour

    Brand of flour products

    Food & beverage products
    Website
14 companies in Missouri

Life sciences companies hiring in Missouri

Explore Missouri life sciences companies with active hiring signals.

  1. Wugen

    Developer of CAR-T cell therapy for treatingT-cell malignancies

    Immunotherapy
    See in list
  2. Geneoscopy

    Developer of non-invasive biomarker tests for colorectal cancer

    Genomics
    See in list
  3. Stereotaxis

    Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care

    Surgical instruments
    See in list
  4. Endevica Bio

    Developer of therapeutic drugs for the treatment of cancer cachexia

    Oncology
    See in list
  5. BioZyme

    Manufacturer of feed additives, vitamin, mineral, trace minerals

    Life sciences platforms and tools
    See in list
5 companies in Missouri
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Missouri compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, the United States1640

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in the United States

1363Acquisition
245Merger
13Takeover

Most active acquirers

  1. Eli lilly18
  2. Merck & Co. Inc.16
  3. Novartis15
  4. Roche AG15
  5. Boston scientific14

Most acquired or merged

  1. Bluebird bio14
  2. Teleflex11
  3. Staar surgical company11
  4. Exact sciences9
  5. Terns pharmaceuticals8

Each deal appears in the events strip at the top of the page.

Go deeper in the life sciences landscape reports:

Life Sciences Industry Landscape of the United States
Industry landscape report

Life Sciences Industry Landscape of the United States

The financials above are one chapter. The full life sciences landscape of Missouri maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of Missouri

Life sciences funding in Missouri

34 life sciences companies in Missouri have recorded equity funding, US$965.33m in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Missouri

Meet the people behind life sciences companies in Missouri. 90 of 144 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Missouri life sciences companies by sub-sector

The most common specialisations among life sciences companies in Missouri. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in Missouri

97 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in Missouri

Browse the Radar directory

Coming soon